438 related articles for article (PubMed ID: 27484093)
21. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
22. Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma.
Shi B; Zhou X; He L; Liang M; Luo Y; Jiang P
BMC Cancer; 2017 Jun; 17(1):414. PubMed ID: 28615075
[TBL] [Abstract][Full Text] [Related]
23. High expression of Zinc-finger protein X-linked promotes tumor growth and predicts a poor outcome for stage II/III colorectal cancer patients.
Yan X; Shan Z; Yan L; Zhu Q; Liu L; Xu B; Liu S; Jin Z; Gao Y
Oncotarget; 2016 Apr; 7(15):19680-92. PubMed ID: 26967242
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells.
Wang L; Shi S; Guo Z; Zhang X; Han S; Yang A; Wen W; Zhu Q
PLoS One; 2013; 8(6):e65539. PubMed ID: 23762387
[TBL] [Abstract][Full Text] [Related]
25. Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.
Gargalionis AN; Korkolopoulou P; Farmaki E; Piperi C; Dalagiorgou G; Adamopoulos C; Levidou G; Saetta A; Fragkou P; Tsioli P; Kiaris H; Zizi-Serbetzoglou A; Karavokyros I; Papavassiliou KA; Tsavaris N; Patsouris E; Basdra EK; Papavassiliou AG
Int J Cancer; 2015 Apr; 136(7):1515-27. PubMed ID: 25123959
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1.
Dou C; Wang Y; Li C; Liu Z; Jia Y; Li Q; Yang W; Yao Y; Liu Q; Tu K
Oncotarget; 2015 May; 6(15):13216-28. PubMed ID: 25965836
[TBL] [Abstract][Full Text] [Related]
27. ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.
Ma F; Bi L; Yang G; Zhang M; Liu C; Zhao Y; Wang Y; Wang J; Bai Y; Zhang Y
Oncol Rep; 2014 Sep; 32(3):1071-7. PubMed ID: 25017610
[TBL] [Abstract][Full Text] [Related]
28. FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer.
Kawase M; Toyama T; Takahashi S; Sato S; Yoshimoto N; Endo Y; Asano T; Kobayashi S; Fujii Y; Yamashita H
Breast Cancer; 2015 May; 22(3):308-16. PubMed ID: 23771556
[TBL] [Abstract][Full Text] [Related]
29. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
[TBL] [Abstract][Full Text] [Related]
30. Aberrant activation of CYR61 enhancers in colorectal cancer development.
Xie L; Song X; Lin H; Chen Z; Li Q; Guo T; Xu T; Su T; Xu M; Chang X; Wang LK; Liang B; Huang D
J Exp Clin Cancer Res; 2019 May; 38(1):213. PubMed ID: 31118064
[TBL] [Abstract][Full Text] [Related]
31. Human cytomegalovirus-encoded US28 may act as a tumor promoter in colorectal cancer.
Cai ZZ; Xu JG; Zhou YH; Zheng JH; Lin KZ; Zheng SZ; Ye MS; He Y; Liu CB; Xue ZX
World J Gastroenterol; 2016 Mar; 22(9):2789-98. PubMed ID: 26973417
[TBL] [Abstract][Full Text] [Related]
32. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
33. PKA RIα/A-kinase anchoring proteins 10 signaling pathway and the prognosis of colorectal cancer.
Wang M; Li Y; Wang R; Wang Z; Chen K; Zhou B; Zhou Z; Sun X
J Gastroenterol Hepatol; 2015 Mar; 30(3):496-503. PubMed ID: 25213315
[TBL] [Abstract][Full Text] [Related]
34. Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer.
Wang J; Cui F; Wang X; Xue Y; Chen J; Yu Y; Lu H; Zhang M; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Feb; 34(1):13. PubMed ID: 25652119
[TBL] [Abstract][Full Text] [Related]
35. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
36. Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases.
Horimoto Y; Arakawa A; Harada-Shoji N; Sonoue H; Yoshida Y; Himuro T; Igari F; Tokuda E; Mamat O; Tanabe M; Hino O; Saito M
Br J Cancer; 2015 Jan; 112(2):345-51. PubMed ID: 25422910
[TBL] [Abstract][Full Text] [Related]
37. Genome-Wide Analysis of the FOXA1 Transcriptional Network Identifies Novel Protein-Coding and Long Noncoding RNA Targets in Colorectal Cancer Cells.
Lazar SB; Pongor L; Li XL; Grammatikakis I; Muys BR; Dangelmaier EA; Redon CE; Jang SM; Walker RL; Tang W; Ambs S; Harris CC; Meltzer PS; Aladjem MI; Lal A
Mol Cell Biol; 2020 Oct; 40(21):. PubMed ID: 32839292
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
[TBL] [Abstract][Full Text] [Related]
39. CXCL10 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Xu Y; Cai S
Mol Biol Rep; 2010 Jul; 37(6):3029-36. PubMed ID: 19821051
[TBL] [Abstract][Full Text] [Related]
40. Gab2 is a novel prognostic factor for colorectal cancer patients.
Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]